Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Peripheral Arterial Disease
Clinical trial register · United States · industry-sponsored

Peripheral Arterial Disease Trials in the USA, 2026

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 9128 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 04 Nov 2026, 03:16 UTC
9128
Studies in scope
industry-sponsored, all four open statuses
4968
Recruiting now
open to new participants
2189
Lead sponsors
across recruiting studies
Top states
Florida 10 California 10 Connecticut 6 Illinois 5 Louisiana 5
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Peripheral Arterial Disease trials in the USA

14 of 9128 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Not yet open
FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease
NCT00424866Peripheral Arterial Disease, Stenosis, Intermittent Claudication
Venturis Therapeutics, Inc.
Phase 1/2
24
Illinois
2028-10-15
Recruiting
The Pharmacokinetics and Pharmacodynamics Study of Evategrel CG-0255 Besylate)and Plavix® in Healthy Participants
NCT07619885Acute Coronary Syndromes (ACS), Recent Myocardial Infarction, Recent Stroke, Peripheral Arterial Disease
Shanghai CureGene Pharmaceutical Co., Ltd.
Phase 1
136
Florida
2026-06
Recruiting
EVERO Drug-coated Balloon (DCB) Randomized Trial
NCT07144150Peripheral Vascular Disease, Peripheral Arterial Disease
Cook Research Incorporated
Not applicable
410
California, Connecticut, Florida, Iowa, Michigan, Mississippi, New Jersey, South Carolina
2026-04-17
Recruiting
Eli Lilly and Company
Phase 3
1,205
Alabama, Arizona, California, Colorado, Florida, Indiana, Maryland, Michigan
2025-10-31
Recruiting
Advanta VXT and Flixene PMCF Registry
NCT07161583Peripheral Arterial Disease
Atrium Medical Corporation
Observational
1,000
Massachusetts
2025-09-25
Recruiting
Nipro Vascular Innovations Americas, Inc
Not applicable
159
Arizona, California, Florida, Georgia, Hawaii, Louisiana, Massachusetts, New Jersey
2024-06-20
Recruiting
W.L.Gore & Associates
Not applicable
244
Arkansas, California, Colorado, Florida, Georgia, Louisiana, Massachusetts, Michigan
2023-10-17
By invitation
The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)
NCT06315023Peripheral Arterial Disease, Symptomatic Femoropopliteal Lesions
Endologix
Observational
450
California, Connecticut, District of Columbia, Florida, Massachusetts, Missouri, New York, Ohio
2023-10-06
Recruiting
Pounce™ Thrombectomy System Retrospective Registry
NCT05868161Peripheral Arterial Disease, Acute Limb Ischemia
SurModics, Inc.
Observational
500
Illinois, Indiana, Louisiana, Minnesota, Ohio, South Carolina, South Dakota, Tennessee
2023-04-18
Recruiting
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
NCT05313165Critical Limb Ischemia, Chronic Limb-Threatening Ischemia, Peripheral Arterial Disease
LimFlow, Inc.
Not applicable
100
California, Connecticut, Florida, Illinois, Massachusetts, Missouri, New Hampshire, New Jersey
2022-12-22
Active, closed
SELUTION4SFA Trial
NCT05132361Peripheral Arterial Disease, Superficial Femoral Artery Stenosis
M.A. Med Alliance S.A.
Not applicable
300
Arkansas, California, Colorado, Connecticut, Florida, Georgia, Illinois, Louisiana
2022-12-01
Recruiting
SELUTION4BTK Trial
NCT05055297Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities
M.A. Med Alliance S.A.
Not applicable
376
Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Illinois
2022-05-19
Active, closed
Micro Medical Solution, Inc.
Not applicable
177
Alabama, Arizona, California, Colorado, Florida, Iowa, Louisiana, Maryland
2020-03-31
Active, closed
BGC101 (EnEPC) Autologous Cell Therapy From Patient's Own Blood for Treatment of Critical Limb Ischemia (CLI)
NCT02805023Chronic Limb-Threatening Ischemia, Peripheral Arterial Disease, Peripheral Vascular Disease
BioGenCell Ltd.
Phase 1/2
40
California, Connecticut, Maryland
2016-06
Rows per page Showing 1–14 of 14
1
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 4 November 2026. https://priyalifescience.com/clinical-trials-usa/condition/peripheral-arterial-disease

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every industry-sponsored study on the registry that lists at least one investigative site in the US and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,128 studies in total at the last sync on 04 Nov 2026, 03:16 UTC. Academic and other non-industry sponsors are out of scope by design. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 14 of those studies listing the condition Peripheral Arterial Disease.

How many Peripheral Arterial Disease trials are recruiting in the US?

9 of the 14 studies on this page are recruiting new participants as of the 04 Nov 2026, 03:16 UTC sync. A further 1 have not yet opened recruitment, 3 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Peripheral Arterial Disease), 14 studies
PhaseStudiesRecruitingShare
Not applicable7550%
Observational3221.4%
Phase 1/22014.3%
Phase 1117.1%
Phase 3117.1%

Most active sponsors

Lead sponsors with the most studies (Peripheral Arterial Disease)
Lead sponsorStudiesRecruiting
M.A. Med Alliance S.A.21
Atrium Medical Corporation11
BioGenCell Ltd.10
Cook Research Incorporated11
Eli Lilly and Company11
Endologix10
LimFlow, Inc.11
Micro Medical Solution, Inc.10
Nipro Vascular Innovations Americas, Inc11
Shanghai CureGene Pharmaceutical Co., Ltd.11

Top states

Top states (Peripheral Arterial Disease), by number of studies with a site there
StateStudies
California10
Florida10
Connecticut6
Colorado5
Illinois5
Louisiana5
Massachusetts5
Arizona4
Georgia4
Arkansas3
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.